Norovirus

Products in Development

The research and development team at MBS strives to develop broadly applicable, quality antibodies that are rich in technical collateral.  Through careful project design and complete control over development and production, the best and most price flexible products possible are added to our growing catalog.

R&D_graphic_Nov13

In Development Notes and Technical Updates:

Dengue Fever:  Subclones are in the final stage of assay validation for the recognition of native Dengue NS1

Campylobactor jejuni: Immunizations are complete with fusion scheduled for the end of November

Chikungunya virus:  Immunizations are complete with first test bleed scheduled for mid November

GST:  Multiple positive clones being assessed and characterized using MultiPure technology

Tetanus Toxoid/Measles/Hib – Project planning phase

If you have a suggestion for a new antibody product please contact us.